Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Observational Study of Safety and Effectiveness Following Administration of Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Egg Derived Vaccine

NCT01101074 is registered in ClinicalTrials.gov with Novartis Vaccines as lead sponsor.

NCT NCT01101074
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01101074 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Observational Study of Safety and Effectiveness Following Administration of Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Egg Derived Vaccine
Lead sponsor
Novartis Vaccines
Phase
Observational
Overall status
Completed
Start date
October 31, 2009
Completion date
September 30, 2010
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

influenza a (h1n1)